Novartis blames former Avexis executives for Zolgensma manipulation

Novartis AG laid the blame for the manipulation of data behind its $2.1 million gene therapy Zolgensma at the feet of the former executives Brian and Allan Kaspar, who it alleges either personally manipulated the data or pressured subordinates to manipulate the data.